Program 2022 – Montpellier

PROGRAM - 4th International Keloid Symposium - Montpellier, France

Time

Speaker

Title

DAY 1
Friday October 7, 2022

08:00 - 08:45
Registration and Morning Coffee
08:45 - 09:00
Michael H. Tirgan, MD
Jouni Uitto, MD, PhD
Welcome to University of Montpellier &
Opening of the 4th International Keloid Symposium
Session 1
09:00 - 10:30
Chair: Jouni Uitto, MD, PhD
Co-Chair: Michael H Tirgan, MD
Setting the Scene: Basic Understanding of Keloid Disorder - Clinical Presentations and Basic Science
09:00 - 09:15
Michael H Tirgan, MD
Clinical Presentation of Keloid Disorder - an Overview
09:15 - 09:25
Omy Itsueli
Psychosocial Impact of Keloid Disorder. How the Disease has Impacted my Life - a Patient's Perspective.
09:25 - 09:45
Jouni Uitto, MD, PhD
Basic Science of Keloid Disorder - an Overview
09:45 - 10:00
Dorothy Supp, PhD
Role of Vitamin D in Keloid Disorder
10:00 - 10:15
Youbin Wang, MD
Definition, Structure and Clinical Application of Keloid Subepidermal Vascular Network Flap. (Live Via Video Link)
10:15 - 10:30
Wei Liu, MD, PhD
Systemic Effect of Inflammation on Keloid Development and Treatment. (Live Via Video Link)

10:30-10:45

Coffee Break

Session 2
10:45 - 12:30
Chair: Fiona Wood, FRCS, FRACS, AM
Co-Chair: Lamont R. Jones, MD, MBA, FACS
Genetics of Keloid Disorder
10:45 - 11:00
Fiona Wood, FRCS, FRACS, AM
Exploring Epigeneics of Scarring and 3D Printing Skin Replacement.
11:00 - 11:15
Lamont R. Jones, MD, MBA, FACS
miRNA profile differentiates keloid and normal skin
11:15 - 11:30
Fiona Wood, FRCS, FRACS, AM
RNA Sequencing of Primary Human Keratinocytes Reveals Epithelial Integrity may be Important in Keloid Pathogenesis
11:30 - 11:45
Akash Gunjan, PhD
Transcriptomic Profiling of Steroid Treated Keloid Fibroblasts Identifies Multiple Potential Biomarkers for Predicting Steroid Responsiveness for Keloid Therapy.
11:45 - 12:00
Dr. Alexandros Onoufriadis
GWAS meta-analysis identifies susceptibility loci for keloids in Europeans.
12:00 - 12:20
Akash Gunjan, PhD
A Multiomics Approach Identifies Multiple Molecular Pathways and Targets for Combination Drug Therapy for Keloid Disease.
12:20 - 12:30
Xiao Long, MD
Single-Cell RNA-Sequencing Reveals Lineage-Specific Regulatory Changes of Fibroblasts and Vascular Endothelial Cells in Keloid. (Live Via Video Link)

12:30-13:30

Lunch Break

Session 3
13:30 - 15:00
Chair: John Glees, MD, FRCR, DMRT
Co-Chair: Reza Ghohestani, MD, PhD
Overall Strategy for Management of Keloid Patients
13:30 - 13:50
John Glees, MD FRCR DMRT
How to Achieve the Best Results in Keloid Tumour /Scar Management Together with your Plastic Surgeon? 40-years Experience.
13:50 - 14:10
Ding Wenyun, MD
Keloid Treatment Strategy at Peking Union Medical Center. (Live Via Video Link)
14:10 - 14:25
Lamont R. Jones, MD, MBA
The Detroit Keloid Scale: A Validated Tool for Rating Keloids
14:25 - 14:40
Reza Ghohestani, MD, PhD
Efficacy of a Comprehensive Approach for the Treatment of Keloids in Various Ethnic Backgrounds
14:40 - 14:55
Ferdinand Nangole, MD, PhD
Determinants of Keloid recurrence: the role of keloid recurrence scoring system.
14:50 - 15:10
Michael H Tirgan MD
KRF Guidelines - Clinical Management of Keloid Lesions
15:10 - 15:15
All Speakers of this Session
Panel Discussion and Q/A

15:15 – 15:30

Coffee Break

Session 4

15:30 – 17:00

Chair: Dorothy Supp, PhD
Co-Chair: Ferdinand Nangole, MD, PhD
Abstract Presentation
15:30 - 15:45
Aflah Elouneg, PhD
Tissue-Scale Modeling of Keloids to Prevent Their Growth
15:45 - 16:00
Kevin Serror, MD
Heterogeneity: a new Insight in Deciphering Keloid Physiopathology
16:00 - 16:15
Ersnt Reichenberger, PhD
Mechanistic Investigations of Keloid Susceptibility Variants (Via Video Link)
16:15 - 16:30
Ferdinand Nangole, MD, PhD
Does Keloids Histology Influence Recurrence?
16:30 - 16:45
Mark Fear, PhD
The Impact of LOX Inhibition on Extracellular Matrix Production and its Potential for the Treatment of Keloids
16:45 - 17:00
Fiona Wood, FRCS, FRACS, AM
Keloid Fibroblasts have Elevated and Dysfunctional Mechanotransduction Signalling that is Independent of TGF-β
Reception
17:00 - 18:30
Everyone is Invited
Time
Speaker
Title

DAY 2
Saturday October 8, 2022

8:00 - 8:45
Registration and Morning Coffee

Session 1

8:45 - 10:30
Chair: Frank Nissen, MD, PhD
Co-Chair: Mohsen Alirezai, MD
Surgicanl Management of Keloid Lesions
08:45 - 09:00
Tae Hwan Park, MD, PhD
Early outcomes of complete excision followed by immediate postoperative single fractional 1000cGy for keloids: One-year follow-up results. (Live via Video Link)
09:00 - 09:15
Ferdinand Nangole, MD, PhD
Treatment outcome of keloid lesions: intralesional vs. extralesional excision followed by post excisional radiation therapy - a comparative study.
09:15 - 09:30
Gottfried Lemperle, MD, PhD
Types of Keloids which may be Removed Surgically without Fear of Recurrence. A Clinical and Histopathological Approach in Africa (Via Video Link)
09:30 - 09:45
Mohsen Alirezai, MD
Technics for Keloid Surgery
09:45 - 10:00
Koorosh Karimi
Worsening of Keloid during Pregnancy

Special Session

10:00 - 10:30
John Glees, MD FRCR DMRT
Michael H Tirgan MD
KRF Annual General Assembly - Planning for 2023 - Meeting Duration - Journal of Keloid Research - Etc.

10:30 – 10:45

Coffee Break

Session 2

10:45 -12:30
Chair: Jouni Uitto, MD, PhD
Co-Chair: Fiona Wood, MD, PhD
Pathogenesis of Keloid Disorder
10:45 - 11:00
Frank Nissen, MD, PhD
Is the Microbiome the Origin of Keloid Formation?
11:00 - 11:15
Chao-Kai Hsu, MD, PhD
The Role of Th2 Inflammation in Keloid Pathogenesis. (Live Via Video Link)
11:15 - 11:30
Kamalendu Malaker, MD, PhD
Perspective on Keloidogenesis and Immune System
11:30 - 11:45
Jong Hee Lee MD, PhD
Fibrovascular Interactions in Keloid Pathogenesis. (Live Via Video Link)
11:45 - 12:00
Qi Yin, MD
The JAK-STAT pathway in keloid formation, a systematic review with qualitative synthesis.
12:00 - 12:15
Young In Lee, MD, PhD
WNT5A Drives IL-6-Dependent Epithelial–Mesenchymal Transition via the JAK/STAT Pathway in Keloid Pathogenesis
12:15 - 12:30
Zélie Dirand, PhD
Keloid Resolution Through Fibrotic Fibroblasts and Macrophages Interaction Study

12:30 – 13:30

Lunch Break

Session 3

13:30 -15:00
Chair: Kannan Prema, MBBS, MCH, FRCS
Co-Chair: Reza Ghohestani, MD, PhD
Non-Surgical Management of Keloid Lesions
13:30 - 13:50
Gisele V Oliveira, MD, PhD
A.S.A.P. - A Simple Algorithm to Treat Keloids and Hypertrophic Scars
13:50 - 14:05
Kannan Prema, MBBS, MCH, FRCS
Keloids and Their Challenges in Our Practice. Is Intralesional Steroid Therapy Our lifeboat??
14:05 - 14:20
Alexa Cohen, MD
Cryotherapy in Combination with Intralesional Triamcinolone Acetonide (IL TAC) Compared to IL TAC alone in the Treatment of Keloids
14:20 - 14:40
Michael H. Tirgan, MD
Intralesional Chemotherapy in Treatment of Keloid Lesions
14:40 - 15:00
Qi Yin, MD
Intralesional corticosteroid administration in the treatment of keloids, a scoping review on injection methods.
15:00 - 15:15
All Speakers of this Session
Panel Discussion and Q/A

15:15 – 15:30

Coffee Break

Session 4

15:30 - 16:30
Chair: Gwenael Rolin, PhD
Co-Chair: Mark Fear, PhD
Abstract Presentations
15:30 - 15:45
Gwenael Rolin, PhD
Can we Consider Spheroids as a Relevant 3D Model for Keloid?
15:45 - 16:00
Mark Fear, PhD
Vitamin D Signaling in Keloid Fibroblasts and Tissue.
16:00 - 16:15
Patricia Yap, MD
The Positive Impact of a Topical Treatment for Keloid Sufferers during the Covid-19 Pandemic.
16:15 - 16:30
Koorosh Karimi
Prevalence of Hypertension among Keloid Patients

Special Session

16:30 - 16:35
Jouni Uitto, MD, PhD
INTRODUCTION - 2022 Annual Jouni Uitto, MD, PhD International Visiting Professorshipand Lecture in Molecular Dermatology

Special Session

16:35 - 17:00
Prof. Alain Mauviel
Transforming Growth Factor-ß and Hippo Signaling Interplay in Skin cells: implications for keloid scars and skin fibrosis

Reception

17:00 – 18:30

Everyone is Invited.

Reception at FAUNE MO.CO. MONTPELLIER

 

Dinner

19:00

Everyone is Invited.

Dinner at FAUNE MO.CO. MONTPELLIER

 

Time
Speaker
Title

DAY 3
Sunday, October 9, 2022

8:00 - 9:00
Registration and Morning Coffee

Session 1

9:00 - 10:30
Translational Medicine and Keloid Disorder – The Clinician Meets the Scientist
09:00 - 09:15

Ferdinand Nangole, MD, PhD

Multiple Cytokines Elevated in Patients with Keloids: Is It an Indication of Auto-Inflammatory Disease?
09:15 - 09:30

Gisele V Oliveira, MD, PhD

Hypertrophic Sars and Keloids: From the Bench to the Keloid Clinic.
09:30 - 9:45

Li Tianhao

USP11 Promotes the Development of Keloid Derived Fibroblasts by De-ubiquitinating TGF-βR2. (Live Via Video Link)
09:45 - 10:00

Stéphane Bordas, PhD

S-Keloid Project, Data-Driven Mathematical Modeling
10:00 - 10:15

Dorothy Supp, PhD

Myofibroblasts are not Characteristic Features of Keloid Lesions
10:15 - 10:30

All Speakers of this Session

Panel Discussion and Q/A

10:30-10:45

Coffee Break

Session 2

10:45 -12:30

Chair: Henry Weatherburn, PhD
C0-Chair: Jonathan Tsao, MD

Basic Understanding and the Role of Radiation Therapy in Treatment of Keloid Lesions
10:45 - 11:00

Jonathan Tsao, MD

Adjuvant Radiotherapy for the Treatment of Keloids
11:00 - 11:20

Henry Weatherburn, PhD

Can Surgical and Radiotherapy Treatment Margins for Keloids be Better Informed by Thermal Imaging?
11:20 - 11:40

John Glees, MD FRCR DMR

Recurrence of Keloid Tumours Following Surgical Excision and a Single Dose of Duperficial Radiotherapy Given within 24 Hours. Long-term Follow up. (Personal Series)
11:40 - 11:55

Akash Gunjan, PhD

A Single Low Dose of Superficial X-Ray Radiation Following Surgical Excision of Keloids Prevents Their Recurrence.
11:55: 12:15

Xiaoli Wu, MD

Laser combined with radiotherapy for keloid treatment: a novel and efficient comprehensive therapy with a low recurrence rate. (Live Via Video Link)
12:15: 12:30

Michael H Tirgan MD

Challenges in the Treatment of Pediatric Keloids
12:30: 12:45

Young-Jun Choi, MD

A retrospective, single-institution cohort analysis on pediatric keloids among Asians.

12:45 – 13:00

Closing Remarks

Closing of the 4th International Keloid Symposium. Plans for our next symposium.

13:00 – 14:00

Lunch Break

Social Event

14:00 – 21:00

Travel to Camargue Natural Reserve and Private Dinner This is a ticketed event with limited space. All participants are required to purchase a ticket.

Social Event

15:00 – 21:00

Travel to Camargue Natural Reserve and Private Dinner This is a ticketed event with limited space. All participants are required to purchase a ticket.